|
2026 Journal Article Alpha-particle therapy with an actinium-225 labeled bivalent inhibitor of prostate-specific membrane antigen is therapeutically efficacious in a mouse model of prostate cancerMorgan, Katherine A., Grieve, Melyssa L., Akhter, Dewan T., Lange, Jaclyn L., Harris, Matthew J., Thurecht, Kristofer J., Paterson, Brett M. and Donnelly, Paul S. (2026). Alpha-Particle Therapy with an Actinium-225 Labeled Bivalent Inhibitor of Prostate-Specific Membrane Antigen is Therapeutically Efficacious in a Mouse Model of Prostate Cancer. Journal of Medicinal Chemistry acs.jmedchem.6c01378. doi: 10.1021/acs.jmedchem.6c01378 |
|
2024 Journal Article Rapid and stable complexation of the α-generators bismuth-212 and lead-212 with a tetraazamacrocyclic chelator bearing thiosemicarbazone pendant armsGrieve, Melyssa L., Davey, Patrick R. W. J., Bernhardt, Paul V., Forsyth, Craig M. and Paterson, Brett M. (2024). Rapid and stable complexation of the α-generators bismuth-212 and lead-212 with a tetraazamacrocyclic chelator bearing thiosemicarbazone pendant arms. Inorganic Chemistry Frontiers, 11 (21), 7307-7323. doi: 10.1039/d4qi01338g |
|
2022 Journal Article The evolving coordination chemistry of radiometals for targeted alpha therapyGrieve, Melyssa L. and Paterson, Brett M. (2022). The evolving coordination chemistry of radiometals for targeted alpha therapy. Australian Journal of Chemistry, 75 (2), 65-88. doi: 10.1071/CH21184 |
|
2021 Journal Article The synthesis of a bis(Thiosemicarbazone) macrocyclic ligand and the Mn(II), Co(II), Zn(II) and 68Ga(III) complexesGrieve, Melyssa L., Davey, Patrick R. W. J., Forsyth, Craig M. and Paterson, Brett M. (2021). The synthesis of a bis(Thiosemicarbazone) macrocyclic ligand and the Mn(II), Co(II), Zn(II) and 68Ga(III) complexes. Molecules, 26 (12) 3646, 3646. doi: 10.3390/molecules26123646 |
